Linked Life Data

15331843

Source:http://linkedlifedata.com/resource/pubmed/id/15331843

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Suppl
pubmed:dateCreated
2004-8-27
pubmed:abstractText
The recent availability of significantly increased levels of funding for unmet medical needs in the developing world, made available by newly created public-private-partnerships, has proven to be a powerful driver for stimulating clinical development of candidate vaccines for malaria. This new way forward promises to greatly increase the likelihood of bringing a safe and effective vaccine to licensure. The investigators bring together important published and unpublished information that illuminates the status of malaria vaccine development. They focus their comments on those candidate vaccines that are currently in or expected to enter clinical trials in the next 12 months.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0002-9637
pubmed:author
pubmed:copyrightInfo
Copyright 2004 The American Society of Tropical Medicine and Hygiene
pubmed:issnType
Print
pubmed:volume
71
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
239-47
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Update on the clinical development of candidate malaria vaccines.
pubmed:affiliation
Clinical Research and Development, and Research and Development, GlaxoSmithKline Biologicals, Rixensart, Belgium. Ripley.Ballou@gskbio.com
pubmed:publicationType
Journal Article, Review